Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients

PURPOSE: Glioblastoma is an aggressive malignant cancer of the central nervous system, with disease progression associated with deterioration of neurocognitive function and quality of life (QoL). As such, maintenance of QoL is an important treatment goal. This analysis presents time to deterioration...

Descripción completa

Detalles Bibliográficos
Autores principales: Wick, Wolfgang, Krendyukov, Andriy, Junge, Klaus, Höger, Thomas, Fricke, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881251/
https://www.ncbi.nlm.nih.gov/pubmed/31679112
http://dx.doi.org/10.1007/s11060-019-03320-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881251/
https://www.ncbi.nlm.nih.gov/pubmed/31679112
http://dx.doi.org/10.1007/s11060-019-03320-x

Ejemplares similares